ইঙ্গিত
Gonal-F is indicated for: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure. Development of multiple follicles in ovulatory infertile women as part of an assisted reproductive technology (ART) cycle. ... Read moreGonal-F is indicated for: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure. Development of multiple follicles in ovulatory infertile women as part of an assisted reproductive technology (ART) cycle. Induction of spermatogenesis in infertile men with azoospermia and primary or secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.
⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।
ফার্মাকোলজি
Follitropin alfa stimulates ovarian follicular growth in women who do not have primary ovarian failure. To bring about final maturation of the follicle and ovulation in the absence of a natural LH surge, human chorionic gonadotropin (hCG) must be given after Follitropin Alfa, once monitoring shows that sufficient follicular development has been achieved. In men with hypogonadotropic hypogonadism, Follitropin Alfa stimulates sperm production when given together with hCG.
Pregnancy & Breastfeeding
Follitropin Alfa should not be used during pregnancy. After some assisted reproductive technology procedures, particularly in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), the rate of congenital malformations may be a little higher than after natural conception. This slightly higher rate is thought to relate to differences in parental characteristics (such as maternal age and the genetic background of both parents and their sperm), as well as to a higher rate of multiple pregnancies following IVF or ICSI. No human data show that gonadotropins, whether Follitropin Alfa alone or as part of an IVF or ICSI cycle, raise the risk of congenital malformations.
There is no information on whether Follitropin Alfa passes into human milk, what effect it may have on a breastfed infant, or what effect it may have on milk production. Since prolactin released during breastfeeding can lead to a poor response to ovarian stimulation, women are advised not to breastfeed while being treated with Follitropin Alfa.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
ডোজ নির্দেশিকা
⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।
পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া
পার্শ্বপ্রতিক্রিয়া
No side-effect data recorded yet.